pentobarbital will minimize the level or outcome of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Use of alternative solutions is strongly advisable when linagliptin is always to be administered with a CYP3A4 inducer
pentobarbital will lower the level or result of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic outcome of elbasvir/grazoprevir may be lowered if coadministered with strong CYP3A inducers and is also as a result contraindicated.
pentobarbital will decrease the level or impact of acalabrutinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lower the extent or result of vardenafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will decrease the level or impact of nicardipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Adhering to oral or parenteral administration, barbiturates readily cross the placental barrier and they are distributed in the course of fetal tissues with maximum concentrations present in the placenta, fetal liver, and Mind; fetal blood amounts solution maternal blood amounts next parenteral administration
pentobarbital will lower the extent or effect of clozapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will lower the level or outcome of montelukast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
pentobarbital will lessen the extent or influence of docetaxel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Not known.
pentobarbital will lessen the extent or effect of dexamethasone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. website Use Caution/Watch.
pentobarbital will minimize the extent or result of cinacalcet by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will lessen the extent or effect of rabeprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.
Premature infants are specifically prone to the depressant effects of barbiturates; if barbiturates are used through labor and supply, resuscitation equipment need to be available
pentobarbital will minimize the extent or outcome of fostemsavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.